Table 5 Top20 genes selected by the early merging strategy (first two columns) and late merging approach (last two columns) in group 2 (immunological tissues)

Fcgr1

12.913

1.65 − 2.28

Gzmb

8.023

2.01 − 4.29

Acod1

12.027

1.49 − 2.40

Ly6c1

7.805

1.77 − 3.58

Il10

10.055

1.15 − 1.59

Plk1

7.701

1.33 − 3.16

Oas1a*

9.377

1.95 − 2.95

Ly6a

7.693

2.09 − 2.74

Irf7*

9.340

2.27 − 3.59

Oas1a*

7.548

1.95 − 2.95

Irgm2

9.283

0.88 − 1.29

Gzma

7.547

1.98 − 4.24

Ms4a6d

9.193

1.37 − 1.48

Oas1f*

7.546

2.13 − 2.83

Oas1f*

8.670

2.13 − 2.83

Oas3*

7.514

2.50 − 2.87

Gbp6

8.635

1.06 − 2.02

Ms4a4c

7.404

0.98 − 2.48

Oas3*

8.330

2.50 − 2.87

Irf7*

7.395

2.27 − 3.59

Brip1

8.297

0.58 − 1.38

Sapcd2

7.384

1.35 − 2.15

Xaf1

8.204

1.60 − 2.27

Ifi204

7.382

1.29 − 2.10

Mlkl

8.172

0.79 − 1.38

Ly6f

7.353

1.90 − 3.11

Isg15

7.984

1.87 − 2.92

Cdk1

7.283

0.90 − 2.55

Ccl2

7.848

1.28 − 1.84

Zbp1

7.282

1.67 − 2.62

Ifit3b

7.753

1.87 − 3.38

Cdca5

7.272

1.33 − 2.89

Oasl2*

7.585

2.06 − 3.04

Oasl2*

7.266

2.06 − 3.04

Hdc

7.534

0.55 − 0.88

Ccnb2

7.252

0.98 − 2.67

Cxcl9

7.479

1.25 − 2.14

Ifitm6

7.234

0.59 − 3.06

Igtp

7.433

1.04 − 1.21

Kif22

7.219

0.76 − 2.54